This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
AUA 2011 - Suprapubic vs. urethral catheter drainage following robot assisted radical prostatectomy: A matched analysis - Session Highlights May 21, 2011
AUA 2011 - Late breaking news: Denosumab to prevent bone metastases (Dmab 147 Study) - Session Highlights May 19, 2011
AUA 2011 - State-of-the-art lecture: Imaging and the treatment of nodal disease in bladder and prostate cancer - Session Highlights May 19, 2011
AUA 2011 - State-of-the-art lecture: What is new in PSA based screening for prostate cancer - An update of the ERSPC study - Session Highlights May 19, 2011
AUA 2011 - State-of-the-art lecture: Prostate cancer susceptibility genes - Session Highlights May 19, 2011
AUA 2011 - State-of-the-art lecture: Risks of imaging and monitoring patients with urologic cancers - Session Highlights May 19, 2011
AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlights May 19, 2011
AUA 2011 - Exploratory efficacy analysis conducted for long-term extension study in patients with prostate cancer treated with Firmagon® or crossed over to Firmagon from leuprolide - Press Release May 19, 2011
AUA 2011 - The VA/NCI/AHRQ CSP#407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer - Session Highligh May 19, 2011
AUA 2011 - Content and construct validation of robotic surgery curriculum using electromagnetic instrument tracker - Session Highlights May 18, 2011
AUA 2011 - Value of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights May 18, 2011
AUA 2011 - Long term complications in men after radical prostatectomy who have early or late radiation - Session Highlights May 18, 2011
AUA 2011 - 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance - Session Highlights May 18, 2011
AUA 2011 - Age and aggressive prostate cancer in patients with low risk characteristics. Implications for conservative management - Session Highlights May 18, 2011
AUA 2011 - Previously developed systems-based biopsy model (Prostate Px+) identifies favorable-risk prostate cancer for men enrolled in an active surveillance program - Session Highlights May 18, 2011
AUA 2011 - Effect of radical prostatectomy on penile shortening - Session Highlights May 18, 2011
AUA 2011 - Characterization of ureter, bladder, and bowel tissue injury after compression with robotic instruments - Session Highlights May 18, 2011
AUA 2011 - Postoperative pain after pure and robot-assisted laparoscopic radical prostatectomy. A prospective randomized study - Session Highlights May 18, 2011
AUA 2011 - Abiraterone acetate plus low-dose prednisone has a favorable safety profile, improves survival and produces PSA and radiographic responses in metastatic castration-resistant prostate cancer progressing after docetaxel-based chemotherapy: Result May 17, 2011
AUA 2011 - Regulatory role of miR-203 in prostate cancer progression and metastasis - Session Highlights May 17, 2011
Page 1412 of 1451
  • Start
  • Prev
  • 1407
  • 1408
  • 1409
  • 1410
  • 1411
  • 1412
  • 1413
  • 1414
  • 1415
  • 1416
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free